Steroid injection behind the eye for light-damage to the retina
Part of Brain & nervous system, Eyes & vision, Injuries & trauma clinical trials.
This study tests whether a steroid injection behind the eye (a retrobulbar injection) can help people whose retina (the light-sensing layer at the back of the eye) has been damaged by looking at a strong light source, like a laser or bright flash. The treatment aims to reduce swelling and vision problems that can follow such an injury.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with retinal light damage (phot injury) after exposure to a bright light source.
- You are experiencing symptoms like wavy or distorted vision or reduced sharpness of vision.
- You are able to undergo eye exams, including optical coherence tomography (OCT), a non-invasive scan of the back of the eye.
- You do not have other eye conditions like severe cataracts, glaucoma, diabetic retinopathy, or a detached retina.
- You have not had eye surgery or trauma to the eye in the past.
- You are not pregnant, planning pregnancy, or breastfeeding.
- You are not currently taking part in another drug trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new eye injection (GenSci148) for people with wet age-related macular degeneration, diabetic macular edema, or retinal vein occlusion. The injection may help reduce swelling and abnormal blood vessel growth in the retina, which can improve or stabilise vision.
This study tests combining vitrectomy (surgery to remove the membrane from the retina) with a dexamethasone implant (a tiny steroid that is placed inside the eye to reduce swelling) for people with a specific type of eye membrane and fluid buildup in the center of the retina.
This trial tests whether a single steroid injection around the back of the eye can improve vision in people with diabetic macular edema (swelling in the center of the retina that blurs vision). It is for people who have not yet had any other eye treatments for this condition.
This trial studies ways to prevent worsening vision caused by radiation damage to the retina after plaque brachytherapy for uveal melanoma. You may be randomly assigned to a medication injection, a steroid implant, or observation to see which approach best protects vision.
This early-stage study tests a new cell-based treatment (C.001) for inherited retinal diseases that affect the back of the eye. The treatment may help slow vision loss or improve sight in people with geographic atrophy or Stargardt disease.
This trial studies a light-guided eye treatment in people with generalized inherited retinal disease (a genetic cause of vision loss). It aims to see whether the approach works safely and can improve function for people whose vision is already significantly reduced.
Hear when a new Retinal Light Damage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.